Risk Profile Improvements

  • Material Weakness (removed) — Stock-based compensation control deficiency identified in 2024 (equity grant exceeded plan limits, expense calculation errors) was remediated; disclosure controls and internal controls now deemed effective.
NYSE: SCCE Sachem Capital Corp. 10-K

Sachem Capital returns to profit, but non-performing loans surge 35% amid debt refinancing

Filed March 13, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 31, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SCCE commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.